August 1993
Volume 34, Issue 9
Free
Articles  |   August 1993
Expression of three forms of melanoma growth stimulating activity (MGSA)/gro in human retinal pigment epithelial cells.
Author Affiliations
  • G J Jaffe
    Department of Ophthalmology, Duke University, Durham, North Carolina.
  • A Richmond
    Department of Ophthalmology, Duke University, Durham, North Carolina.
  • L Van Le
    Department of Ophthalmology, Duke University, Durham, North Carolina.
  • R L Shattuck
    Department of Ophthalmology, Duke University, Durham, North Carolina.
  • Q C Cheng
    Department of Ophthalmology, Duke University, Durham, North Carolina.
  • F Wong
    Department of Ophthalmology, Duke University, Durham, North Carolina.
  • W Roberts
    Department of Ophthalmology, Duke University, Durham, North Carolina.
Investigative Ophthalmology & Visual Science August 1993, Vol.34, 2776-2785. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      G J Jaffe, A Richmond, L Van Le, R L Shattuck, Q C Cheng, F Wong, W Roberts; Expression of three forms of melanoma growth stimulating activity (MGSA)/gro in human retinal pigment epithelial cells.. Invest. Ophthalmol. Vis. Sci. 1993;34(9):2776-2785.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

PURPOSE: To characterize mRNA expression and protein production of the cytokine MGSA/gro in human retinal pigment epithelial (RPE) cells and to determine whether expression of MGSA/gro is modulated by serum and the cytokines interleukin 1 beta (IL-1 beta), tumor necrosis factor alpha (TNF alpha), or transforming growth factor beta (TGF beta) mediators implicated in proliferative vitreoretinopathy (PVR). METHODS: Reverse-transcription polymerase chain reaction was used to determine the steady-state mRNA expression of three forms of MGSA/gro, alpha, beta, and gamma, by cultured human RPE cells in the presence or absence of recombinant IL-1 beta, TNF alpha, or TGF beta, or when serum-starved cells were re-fed with medium containing serum. Immunocytochemistry was used to characterize RPE cell-associated MGSA/gro protein, and immunoprecipitation of MGSA/gro from cell-conditioned medium was used to demonstrate MGSA/gro secretion. RESULTS: MGSA/gro mRNA was expressed minimally under basal conditions. Expression for all three forms of MGSA/gro mRNA was induced in a dose- and time-dependent manner after exposure to IL-1 beta, to a lesser extent after exposure to TNF alpha, but not after exposure to TGF beta. Serum induced MGSA/gro alpha and gamma transcripts, but not beta transcripts. Cell-associated MGSA/gro was identified on RPE cells grown in the absence of cytokines, but MGSA/gro was not secreted under these conditions. Exposure to IL-1 beta did not consistently cause increased cell-associated MGSA/gro; however, IL-1 beta induced secretion of MGSA/gro in a time-dependent manner. CONCLUSION: MGSA/gro is produced by human RPE in response to mediators implicated in PVR. Because MGSA/gro is a pleiotropic modulator of cell proliferation and inflammation, it may contribute to the intraocular wound healing response that characterizes PVR.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×